GORDON STEPHEN (Chief Financial Officer) sold 8.8% of their position (2.06K shares) of TRANSMEDICS GROUP, INC. on the open market
Open‑market sale worth $280.0K — a moderate reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 6/5/2024ACC: 0000950170-24-069424
Officer· Chief Financial Officer
Since May 2019
-2.06K
Net shares
Net seller
$280.0K
Total sold
1
Open market trades
0B · 1S
3
Total transactions
2.06K acquired · 4.12K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
+2.06K
Price / share
$38.46
Trade value
$79.23K
% of position
9.7%
6/3/2024
21.30K→23.36K
Common Stock
Direct
Shares
−2.06K
Price / share
$135.93
Trade value
$280.02K
% of position
8.8%
6/3/2024
23.36K→21.30K
Total
Net shares
+0.00
Net value
-$200.79K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 6/3/2024 | M · Option Exercise | +2.06K | $38.46 | $79.23K | 9.7% | 21.30K | 23.36K |
| Common Stock Direct | 6/3/2024 | S · Sale | −2.06K | $135.93 | $280.02K | 8.8% | 23.36K | 21.30K |
| Total | +0.00 | -$200.79K | ||||||
Derivative Transactions1
Stock Option (Right to Buy)
Direct
Converts to
Common Stock
2.06K shares
Shares
−2.06K
Strike price
38.46
Held after
15.42K
Exercisable
—
6/3/2024
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy) Direct | Common Stock2.06K shares | 6/3/2024 | M · Option Exercise | −2.06K | 38.46 | — | 15.42K |